ErbB3 has not been as extensively studied, but analysis of clinical prostate cancer specimens indicates that overexpression of ErbB3 has been linked to a less favourable prognosis (Leung et al, 1997). The gene discussed is ERBB3; the disease is prostate carcinoma.